Vasoactive intestinal peptide exerts therapeutic action by regulating PTEN in a model of Sjögren's disease
Abstract Introduction Sjögren's disease (SjD) is a chronic autoimmune disease characterized by the loss of the secretory function of the exocrine glands. At present, drugs that can both correct the immune imbalance and improve exocrine gland function are needed. Meanwhile, vasoactive intestinal...
Main Authors: | Yixi Li, Wen Zhu, Rui Lin, Junjie Zhao, Yue Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-07-01
|
Series: | Immunity, Inflammation and Disease |
Subjects: | |
Online Access: | https://doi.org/10.1002/iid3.936 |
Similar Items
-
Vasoactive intestinal polypeptide level in gastroesophageal reflux disease before and after surgical treatment
by: Ye. I. Haidarzhi, et al.
Published: (2023-07-01) -
Immunomodulatory role of vasoactive intestinal peptide and ghrelin in Oncorhynchus mykiss
by: Carolina Muñoz-Flores, et al.
Published: (2023-12-01) -
Effect of Acrylamide Supplementation on the Population of Vasoactive Intestinal Peptide (VIP)-Like Immunoreactive Neurons in the Porcine Small Intestine
by: Katarzyna Palus, et al.
Published: (2020-12-01) -
Pressure-Dependent Elevation of Vasoactive Intestinal Peptide Level in Chicken Choroid
by: Evgeny Privalov, et al.
Published: (2023-03-01) -
Chronic Diarrhea Caused by Vasoactive Intestinal Peptide-Secreting Tumor
by: Oana Belei, et al.
Published: (2023-09-01)